Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Equity (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Return on Equity for 13 consecutive years, with 0.24% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 2.0% to 0.24% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.24%, a 2.0% increase, with the full-year FY2025 number at 0.28%, up 5.0% from a year prior.
  • Return on Equity was 0.24% for Q4 2025 at Niagen Bioscience, down from 0.3% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.3% in Q3 2025 to a low of 1.21% in Q2 2022.
  • A 5-year average of 0.34% and a median of 0.28% in 2023 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: soared 90bps in 2021, then crashed -67bps in 2022.
  • Niagen Bioscience's Return on Equity stood at 0.81% in 2021, then increased by 7bps to 0.75% in 2022, then soared by 75bps to 0.18% in 2023, then soared by 216bps to 0.21% in 2024, then rose by 11bps to 0.24% in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Return on Equity are 0.24% (Q4 2025), 0.3% (Q3 2025), and 0.3% (Q2 2025).